Assessing the effects of National Health Insurance reimbursement policy revisions for anti-osteoporotic drugs in Korean women aged 50 or older.
Ja Seo KooSeong Hwan MoonHankil LeeSohee ParkYun Mi YuHye-Young KangPublished in: PloS one (2020)
Although the two revisions expanded reimbursement coverage, only the second revision on reimbursing based on osteoporotic fracture regardless of bone mineral density was associated with increasing the proportion of post-menopausal women being treated with anti-osteoporotic drugs.
Keyphrases
- bone mineral density
- health insurance
- postmenopausal women
- affordable care act
- body composition
- polycystic ovary syndrome
- pregnancy outcomes
- healthcare
- total knee arthroplasty
- public health
- mental health
- breast cancer risk
- physical activity
- quality improvement
- pregnant women
- insulin resistance
- community dwelling
- adipose tissue
- middle aged
- newly diagnosed
- metabolic syndrome
- drug induced
- hip fracture